•
The National Medical Products Administration (NMPA) has coordinated the revision and release of the In Vitro Diagnostic Reagents (IVDs) Classification List, which will come into effect from January 1, 2025. The list includes IVDs regulated as medical devices, excluding those used for blood source screening and those labeled with radioactive…